$1,509.9m metering disposal lifted NPAT; continuing PBT fell 32.8%

Continuing operations produced $112.6m. Group profit before tax was $159.7m, down 32.8% from FY22's $237.8m.

• Revenue fell 11.0% to $1.2b. Group EBITDA was essentially unchanged at $510.2m. Operating cash flow held at $517.1m versus $518.8m the prior year.
• Capex rose 28.3% to $700.4m, taking pre-lease free cash flow to -$183.3m from -$27.1m. Disposal proceeds were applied to debt: net debt fell to $2.2b from $3.2b, and net debt/EBITDA moved from 6.3x to 4.3x. The full-year dividend rose to 22.25 cps from 16.75 cps, including a 5.5 cps special dividend inside the 14.0 cps final.

The cleaner read is continuing PBT down 32.8% on revenue down 11.0%. Both sit at unprecedented lows against Annolyse's historical baseline (PBT growth mean +26.8%, range -7.0% to +67.6%; revenue growth mean -1.0%, range -4.3% to +4.7%). The disposal gain inflates both reported NPAT and ROE (43.4% versus a 4.5% historical mean), but neither is repeatable.

Free cash flow deteriorated through investment, not working capital. Pre-lease FCF of -$183.3m is well outside the historical range of -$30.4m to +$45.1m (mean -$4.1m). Cash conversion at 101.4% sits inside the normal band, and the working-capital movement of -$34.5m is also within range. The gap is the 28.3% step-up in capex to $700.4m, which now exceeds operating cash flow by roughly $183m.

The balance sheet has been reset, but on a lower continuing earnings base. Net debt/EBITDA at 4.3x is at the lower edge of the historical range (mean 5.26x). That improvement reflects disposal proceeds rather than retained earnings, so future capacity depends on whether the slimmed continuing business can support both the elevated capex profile and the higher dividend.

Because FY22 includes a fully consolidated metering business and FY23 separates it as a discontinued operation, the year-on-year movements are not a clean like-for-like read.

The HY23 anchor (NPAT $100.3m, adjusted EBITDA $274.0m up 3.9%) is consistent with continuing operations being roughly half-and-half across the year; the disposal gain landed entirely in the second half. That timing matters because it concentrates almost all of the equity uplift, debt reduction and special-dividend headroom into a single event rather than a recurring trend.

Strip it out and continuing PBT is down meaningfully on a revenue base that contracted 11.0%. EBITDA margin at 42.8% screens above Annolyse's historical range (mean 38.2%, range 36.3% to 40.1%), but the discontinued metering treatment changes the revenue and cost mix, so a clean margin trend is not reliable from this disclosure.

Cash quality on the continuing business is intact — OCF/EBITDA at 101.4% sits in the historical band — but capital intensity has stepped up sharply, and the dividend now sits alongside a -$183.3m pre-lease free-cash deficit. The 22.25 cps full-year dividend equates to a 13.0% payout against the inflated NPAT; against continuing operations earnings alone it is materially higher, and that is the basis a forward-looking investor needs to consider before the policy review.

This briefing cannot assess the standalone economics of the retained 50% Vector Metering interest or the eventual outcome of the dividend-policy review.